Stitch Fix Inc vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Stitch Fix Inc trades at $2.74 (market cap $365.41M), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: SELLAS Life Sciences Group Inc. Common Stock is far larger — about 6.2× Stitch Fix Inc's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, Stitch Fix Inc nearer its low. Which is the better fit depends on your goals.
| SFIX | SLS | |
|---|---|---|
Market Cap | $365.41M | $2.28B |
Volume | 3,317,935 | 3,128,960 |
Sector | Consumer Cyclical | Health |
52-Week High | $5.64 | $15.46 |
52-Week Low | $2.16 | $1.39 |
Typical Hold Time | 31 Days | — |
Enterprise Value | $261.21M | $2.15B |
Signals from Pluang's Aura AI — not financial advice
Stitch Fix (SFIX) trades at $2.73, up 2.25% today, showing recent earnings beats but facing bearish technical signals. The company reported improved financials with narrowing losses (-$28.74M net income in 2025 vs -$129M in 2024) and stable $1.27B revenue, though negative cash flow and weak FY27 guidance weigh on sentiment. Analyst consensus is mixed with 24% Buy ratings but a $3.40 price target suggesting 25% upside.
Outlook remains challenging with ongoing profitability concerns and legal investigations creating headwinds. The stock offers speculative appeal given low P/S ratio and AI-driven growth initiatives, but execution risks and competitive pressures require careful monitoring. Near-term performance hinges on reversing active client declines and achieving sustainable EBITDA positivity.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →